Constellation Pharmaceuticals Garners $5,000,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=53480e79-b3e7-4280-8ecb-14dc4b8d9561 - Date
8/5/2014 - Company Name
Constellation Pharmaceuticals - Mailing Address
215 First Street Cambridge, MA 02142 USA - Company Description
Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression. - Website
http://www.constellationpharma.com - Transaction Type
Venture Equity - Transaction Amount
$5,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
